Lipofibromatosis-like neural tumor (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Lipofibromatosis-like neural tumor" in English language version.

refsWebsite

Global rank English rank

21nih.gov

4^th place

14doi.org

2^nd place

7semanticscholar.org

11^th place

8^th place

doi.org (Global: 2^nd place; English: 2^nd place)

Agaram NP, Zhang L, Sung YS, Chen CL, Chung CT, Antonescu CR, Fletcher CD (October 2016). "Recurrent NTRK1 Gene Fusions Define a Novel Subset of Locally Aggressive Lipofibromatosis-like Neural Tumors". The American Journal of Surgical Pathology. 40 (10): 1407–16. doi:10.1097/PAS.0000000000000675. PMC 5023452. PMID 27259011.
Crumbach L, Descotes F, Bringuier PP, Poulalhon N, Balme B, Juliet T, Lopez J, Harou O (November 2020). "Lipofibromatosis-Like Neural Tumor: A Case Report and Review of the Literature". The American Journal of Dermatopathology. 42 (11): 881–884. doi:10.1097/DAD.0000000000001734. PMID 32618702. S2CID 220327572.
Dupuis M, Shen Y, Curcio C, Meis JM, Wang WL, Amini B, Rhines L, Reuther J, Roy A, Fisher KE, Conley AP, Andrew Livingston J (2020). "Successful treatment of lipofibromatosis-like neural tumor of the lumbar spine with an NTRK-fusion inhibitor". Clinical Sarcoma Research. 10: 14. doi:10.1186/s13569-020-00136-6. PMC 7412810. PMID 32782782.
Panse G, Reisenbichler E, Snuderl M, Wang WL, Laskin W, Jour G (February 2021). "LMNA-NTRK1 rearranged mesenchymal tumor (lipofibromatosis-like neural tumor) mimicking pigmented dermatofibrosarcoma protuberans". Journal of Cutaneous Pathology. 48 (2): 290–294. doi:10.1111/cup.13772. PMID 32519338. S2CID 219562066.
Wang H, Chen L (December 2020). "[Clinicopathological and molecular genetic features of lipofibromatosis-like neural tumor]". Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology (in Chinese). 49 (12): 1272–1275. doi:10.3760/cma.j.cn112151-20200319-00231. PMID 33287512.
Malik F, Santiago T, Newman S, McCarville B, Pappo AS, Clay MR (June 2020). "An addition to the evolving spectrum of lipofibromatosis and lipofibromatosis-like neural tumor: Molecular findings in an unusual phenotype aid in accurate classification". Pathology, Research and Practice. 216 (6) 152942. doi:10.1016/j.prp.2020.152942. PMID 32299759. S2CID 215803522.
Suurmeijer AJ, Dickson BC, Swanson D, Zhang L, Sung YS, Cotzia P, Fletcher CD, Antonescu CR (December 2018). "A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes". Genes, Chromosomes & Cancer. 57 (12): 611–621. doi:10.1002/gcc.22671. PMC 6746236. PMID 30276917.
Lao IW, Sun M, Zhao M, Yu L, Wang J (August 2018). "Lipofibromatosis-like neural tumour: a clinicopathological study of ten additional cases of an emerging novel entity". Pathology. 50 (5): 519–523. doi:10.1016/j.pathol.2018.03.007. PMID 29958731. S2CID 49615346.
Hung YP, Fletcher CD, Hornick JL (October 2018). "Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics". Histopathology. 73 (4): 634–644. doi:10.1111/his.13666. PMID 29863809. S2CID 44131360.
Rekhi B, Shetty O, Bapat P, Gurav M, Qureshi S (February 2021). "A Case of Inv(1)(q23q31) TPR-NTRK1 Fusion-Positive Spindle Cell Neoplasm in an Infant-Uncovered by Next-Generation Sequencing: Diagnostic Challenge, Review, and Therapeutic Implications". International Journal of Surgical Pathology. 29 (1): 102–108. doi:10.1177/1066896920927467. PMID 32489127. S2CID 219284010.
Parham DM (2018). "Fibroblastic and myofibroblastic tumors of children: new genetic entities and new ancillary testing". F1000Research. 7: 1963. doi:10.12688/f1000research.16236.1. PMC 6305242. PMID 30613391.
Al-Ibraheemi A, Folpe AL, Perez-Atayde AR, Perry K, Hofvander J, Arbajian E, Magnusson L, Nilsson J, Mertens F (March 2019). "Aberrant receptor tyrosine kinase signaling in lipofibromatosis: a clinicopathological and molecular genetic study of 20 cases". Modern Pathology. 32 (3): 423–434. doi:10.1038/s41379-018-0150-3. PMID 30310176. S2CID 52962101.
Kojadinovic A, Laderian B, Mundi PS (August 2021). "Targeting TRK: A fast-tracked application of precision oncology and future directions". Critical Reviews in Oncology/Hematology. 165 103451. doi:10.1016/j.critrevonc.2021.103451. PMID 34389458.
Han SY (June 2021). "TRK Inhibitors: Tissue-Agnostic Anti-Cancer Drugs". Pharmaceuticals (Basel, Switzerland). 14 (7): 632. doi:10.3390/ph14070632. PMC 8308490. PMID 34209967.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Agaram NP, Zhang L, Sung YS, Chen CL, Chung CT, Antonescu CR, Fletcher CD (October 2016). "Recurrent NTRK1 Gene Fusions Define a Novel Subset of Locally Aggressive Lipofibromatosis-like Neural Tumors". The American Journal of Surgical Pathology. 40 (10): 1407–16. doi:10.1097/PAS.0000000000000675. PMC 5023452. PMID 27259011.
Crumbach L, Descotes F, Bringuier PP, Poulalhon N, Balme B, Juliet T, Lopez J, Harou O (November 2020). "Lipofibromatosis-Like Neural Tumor: A Case Report and Review of the Literature". The American Journal of Dermatopathology. 42 (11): 881–884. doi:10.1097/DAD.0000000000001734. PMID 32618702. S2CID 220327572.
Dupuis M, Shen Y, Curcio C, Meis JM, Wang WL, Amini B, Rhines L, Reuther J, Roy A, Fisher KE, Conley AP, Andrew Livingston J (2020). "Successful treatment of lipofibromatosis-like neural tumor of the lumbar spine with an NTRK-fusion inhibitor". Clinical Sarcoma Research. 10: 14. doi:10.1186/s13569-020-00136-6. PMC 7412810. PMID 32782782.
Panse G, Reisenbichler E, Snuderl M, Wang WL, Laskin W, Jour G (February 2021). "LMNA-NTRK1 rearranged mesenchymal tumor (lipofibromatosis-like neural tumor) mimicking pigmented dermatofibrosarcoma protuberans". Journal of Cutaneous Pathology. 48 (2): 290–294. doi:10.1111/cup.13772. PMID 32519338. S2CID 219562066.
Wang H, Chen L (December 2020). "[Clinicopathological and molecular genetic features of lipofibromatosis-like neural tumor]". Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology (in Chinese). 49 (12): 1272–1275. doi:10.3760/cma.j.cn112151-20200319-00231. PMID 33287512.
Malik F, Santiago T, Newman S, McCarville B, Pappo AS, Clay MR (June 2020). "An addition to the evolving spectrum of lipofibromatosis and lipofibromatosis-like neural tumor: Molecular findings in an unusual phenotype aid in accurate classification". Pathology, Research and Practice. 216 (6) 152942. doi:10.1016/j.prp.2020.152942. PMID 32299759. S2CID 215803522.
Suurmeijer AJ, Dickson BC, Swanson D, Zhang L, Sung YS, Cotzia P, Fletcher CD, Antonescu CR (December 2018). "A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes". Genes, Chromosomes & Cancer. 57 (12): 611–621. doi:10.1002/gcc.22671. PMC 6746236. PMID 30276917.
Lao IW, Sun M, Zhao M, Yu L, Wang J (August 2018). "Lipofibromatosis-like neural tumour: a clinicopathological study of ten additional cases of an emerging novel entity". Pathology. 50 (5): 519–523. doi:10.1016/j.pathol.2018.03.007. PMID 29958731. S2CID 49615346.
Hung YP, Fletcher CD, Hornick JL (October 2018). "Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics". Histopathology. 73 (4): 634–644. doi:10.1111/his.13666. PMID 29863809. S2CID 44131360.
Rekhi B, Shetty O, Bapat P, Gurav M, Qureshi S (February 2021). "A Case of Inv(1)(q23q31) TPR-NTRK1 Fusion-Positive Spindle Cell Neoplasm in an Infant-Uncovered by Next-Generation Sequencing: Diagnostic Challenge, Review, and Therapeutic Implications". International Journal of Surgical Pathology. 29 (1): 102–108. doi:10.1177/1066896920927467. PMID 32489127. S2CID 219284010.
Parham DM (2018). "Fibroblastic and myofibroblastic tumors of children: new genetic entities and new ancillary testing". F1000Research. 7: 1963. doi:10.12688/f1000research.16236.1. PMC 6305242. PMID 30613391.
Al-Ibraheemi A, Folpe AL, Perez-Atayde AR, Perry K, Hofvander J, Arbajian E, Magnusson L, Nilsson J, Mertens F (March 2019). "Aberrant receptor tyrosine kinase signaling in lipofibromatosis: a clinicopathological and molecular genetic study of 20 cases". Modern Pathology. 32 (3): 423–434. doi:10.1038/s41379-018-0150-3. PMID 30310176. S2CID 52962101.
Kojadinovic A, Laderian B, Mundi PS (August 2021). "Targeting TRK: A fast-tracked application of precision oncology and future directions". Critical Reviews in Oncology/Hematology. 165 103451. doi:10.1016/j.critrevonc.2021.103451. PMID 34389458.
Han SY (June 2021). "TRK Inhibitors: Tissue-Agnostic Anti-Cancer Drugs". Pharmaceuticals (Basel, Switzerland). 14 (7): 632. doi:10.3390/ph14070632. PMC 8308490. PMID 34209967.

ncbi.nlm.nih.gov

Agaram NP, Zhang L, Sung YS, Chen CL, Chung CT, Antonescu CR, Fletcher CD (October 2016). "Recurrent NTRK1 Gene Fusions Define a Novel Subset of Locally Aggressive Lipofibromatosis-like Neural Tumors". The American Journal of Surgical Pathology. 40 (10): 1407–16. doi:10.1097/PAS.0000000000000675. PMC 5023452. PMID 27259011.
Dupuis M, Shen Y, Curcio C, Meis JM, Wang WL, Amini B, Rhines L, Reuther J, Roy A, Fisher KE, Conley AP, Andrew Livingston J (2020). "Successful treatment of lipofibromatosis-like neural tumor of the lumbar spine with an NTRK-fusion inhibitor". Clinical Sarcoma Research. 10: 14. doi:10.1186/s13569-020-00136-6. PMC 7412810. PMID 32782782.
Suurmeijer AJ, Dickson BC, Swanson D, Zhang L, Sung YS, Cotzia P, Fletcher CD, Antonescu CR (December 2018). "A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes". Genes, Chromosomes & Cancer. 57 (12): 611–621. doi:10.1002/gcc.22671. PMC 6746236. PMID 30276917.
"LMNA lamin A/C [Homo sapiens (Human)] - Gene - NCBI".
"TPR translocated promoter region, nuclear basket protein [Homo sapiens (Human)] - Gene - NCBI".
Parham DM (2018). "Fibroblastic and myofibroblastic tumors of children: new genetic entities and new ancillary testing". F1000Research. 7: 1963. doi:10.12688/f1000research.16236.1. PMC 6305242. PMID 30613391.
Han SY (June 2021). "TRK Inhibitors: Tissue-Agnostic Anti-Cancer Drugs". Pharmaceuticals (Basel, Switzerland). 14 (7): 632. doi:10.3390/ph14070632. PMC 8308490. PMID 34209967.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Crumbach L, Descotes F, Bringuier PP, Poulalhon N, Balme B, Juliet T, Lopez J, Harou O (November 2020). "Lipofibromatosis-Like Neural Tumor: A Case Report and Review of the Literature". The American Journal of Dermatopathology. 42 (11): 881–884. doi:10.1097/DAD.0000000000001734. PMID 32618702. S2CID 220327572.
Panse G, Reisenbichler E, Snuderl M, Wang WL, Laskin W, Jour G (February 2021). "LMNA-NTRK1 rearranged mesenchymal tumor (lipofibromatosis-like neural tumor) mimicking pigmented dermatofibrosarcoma protuberans". Journal of Cutaneous Pathology. 48 (2): 290–294. doi:10.1111/cup.13772. PMID 32519338. S2CID 219562066.
Malik F, Santiago T, Newman S, McCarville B, Pappo AS, Clay MR (June 2020). "An addition to the evolving spectrum of lipofibromatosis and lipofibromatosis-like neural tumor: Molecular findings in an unusual phenotype aid in accurate classification". Pathology, Research and Practice. 216 (6) 152942. doi:10.1016/j.prp.2020.152942. PMID 32299759. S2CID 215803522.
Lao IW, Sun M, Zhao M, Yu L, Wang J (August 2018). "Lipofibromatosis-like neural tumour: a clinicopathological study of ten additional cases of an emerging novel entity". Pathology. 50 (5): 519–523. doi:10.1016/j.pathol.2018.03.007. PMID 29958731. S2CID 49615346.
Hung YP, Fletcher CD, Hornick JL (October 2018). "Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics". Histopathology. 73 (4): 634–644. doi:10.1111/his.13666. PMID 29863809. S2CID 44131360.
Rekhi B, Shetty O, Bapat P, Gurav M, Qureshi S (February 2021). "A Case of Inv(1)(q23q31) TPR-NTRK1 Fusion-Positive Spindle Cell Neoplasm in an Infant-Uncovered by Next-Generation Sequencing: Diagnostic Challenge, Review, and Therapeutic Implications". International Journal of Surgical Pathology. 29 (1): 102–108. doi:10.1177/1066896920927467. PMID 32489127. S2CID 219284010.
Al-Ibraheemi A, Folpe AL, Perez-Atayde AR, Perry K, Hofvander J, Arbajian E, Magnusson L, Nilsson J, Mertens F (March 2019). "Aberrant receptor tyrosine kinase signaling in lipofibromatosis: a clinicopathological and molecular genetic study of 20 cases". Modern Pathology. 32 (3): 423–434. doi:10.1038/s41379-018-0150-3. PMID 30310176. S2CID 52962101.